Research and Markets has announced the addition of the "The Global Market for Nanocellulose To 2020" report to their offering.
Even in a crowded room full of background noise, the human ear is remarkably adept at tuning in to a single voice — a feat that has proved remarkably difficult for computers to match. A new analysis of the underlying mechanisms, conducted by researchers at MIT, has provided insights that could ultimately lead to better machine hearing, and perhaps to better hearing aids as well.
Researchers at UPM are experimenting the introduction of aluminum optical nanosensors on the surface of common compact disc for facilitating analysis by using CDs and DVDs players.
Plants have many valuable functions: They provide food and fuel, release the oxygen that we breathe, and add beauty to our surroundings. Now, a team of MIT researchers wants to make plants even more useful by augmenting them with nanomaterials that could enhance their energy production and give them completely new functions, such as monitoring environmental pollutants.
Move over, nanotechnologists, and make room for the biggest of the small. Scientists at the Harvard's Wyss Institute have built a set of self-assembling DNA cages one-tenth as wide as a bacterium. The structures are some of the largest and most complex structures ever constructed solely from DNA, they report today's online edition of Science.
International Self-Powered Building Council (ISPBC) showcased its world-exclusive self-cleaning XTIO2 GLOBAL Travel Facemask for travelers with the world’s highest protection: 100%, proven by SGS U.S. Laboratories.
Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today reported its financial results for the fourth quarter and year ended December 31, 2013 and announced the initiation of a Phase 1/2 clinical trial of its H7N9 avian influenza VLP vaccine candidate with its proprietary Matrix-M adjuvant.
Jason Reed, Ph.D., is a sort of research jack-of-all-trades. He has a broad base of knowledge to pull from – an undergraduate and master’s degrees in physics and a Ph.D. in physical chemistry. While in his doctoral program, he focused on genome analysis of single DNA molecules. Since then, he has focused his research on biological systems – applying imaging approaches that look at how cancer cells grow or how they respond to treatment.
Nanoparticles designed for drug delivery run the gamut from very artificial components like gold or specially designed RNA to particles that adapt or mimic naturally occurring nanoparticles. A noteworthy example of the latter is adapting biology’s “good cholesterol”, the high-density lipoprotein particle, to deliver anti-inflammatory drugs to prevent recurrent heart attacks and strokes.
Rice University researchers have developed a theoretical approach to analyze the process by which protein building blocks form the biopolymer skeletons of living cells.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.